Clinical utility of circulating tumor DNA in human cancers-Reference-Cited by-同舟云学术

Clinical utility of circulating tumor DNA in human cancers

Published:2015-07-02 Issue:4 Volume:8 Page:222-226
ISSN:1865-5041
Container-title:memo - Magazine of European Medical Oncology
language:en
Short-container-title:memo

Author:

Heitzer Ellen

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12254-015-0217-5.pdf

Reference36 articles.

1. Schilsky RL. Implementing personalized cancer care. Nat Rev Clin Oncol. 2014;11(7):432–8. PubMed PMID: 24687035.

2. Jamal-Hanjani M, Quezada SA, Larkin J, Swanton C. Translational Implications of tumor heterogeneity. Clin Cancer Res. 2015;21(6):1258–66. PubMed PMID: 25770293. Pubmed Central PMCID: 4374162.

3. Gerlinger M. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–92.

4. Mandel PMP. Les acides nucleiques du plasma sanguin chez l’homme [in French]. Seances Soc Biol Fil. 1948;142:241–3.

5. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(3):646–50. PubMed PMID: 837366.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near-Infrared Light Regulation of Capture and Release of ctDNA Platforms Based on the DNA Assembly System;Frontiers in Bioengineering and Biotechnology;2022-06-22

2. The potential of liquid biopsies;Current Opinion in Oncology;2016-03

3. Biomarkers—hope and hype;memo - Magazine of European Medical Oncology;2015-12